Literature DB >> 29376444

Hot-spot analysis for drug discovery targeting protein-protein interactions.

Mireia Rosell1, Juan Fernández-Recio1,2.   

Abstract

INTRODUCTION: Protein-protein interactions are important for biological processes and pathological situations, and are attractive targets for drug discovery. However, rational drug design targeting protein-protein interactions is still highly challenging. Hot-spot residues are seen as the best option to target such interactions, but their identification requires detailed structural and energetic characterization, which is only available for a tiny fraction of protein interactions. Areas covered: In this review, the authors cover a variety of computational methods that have been reported for the energetic analysis of protein-protein interfaces in search of hot-spots, and the structural modeling of protein-protein complexes by docking. This can help to rationalize the discovery of small-molecule inhibitors of protein-protein interfaces of therapeutic interest. Computational analysis and docking can help to locate the interface, molecular dynamics can be used to find suitable cavities, and hot-spot predictions can focus the search for inhibitors of protein-protein interactions. Expert opinion: A major difficulty for applying rational drug design methods to protein-protein interactions is that in the majority of cases the complex structure is not available. Fortunately, computational docking can complement experimental data. An interesting aspect to explore in the future is the integration of these strategies for targeting PPIs with large-scale mutational analysis.

Keywords:  Protein-protein interactions; computational docking; drug discovery; interface hot-spot residues

Mesh:

Substances:

Year:  2018        PMID: 29376444     DOI: 10.1080/17460441.2018.1430763

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  16 in total

1.  Proteomics for cancer drug design.

Authors:  Amanda Haymond; Justin B Davis; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2019-08-04       Impact factor: 3.940

2.  Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing.

Authors:  E Sila Ozdemir; Farideh Halakou; Ruth Nussinov; Attila Gursoy; Ozlem Keskin
Journal:  Methods Mol Biol       Date:  2019

Review 3.  Crystallographic mining of ASK1 regulators to unravel the intricate PPI interfaces for the discovery of small molecule.

Authors:  Ashish Kumar Agrahari; Madhu Dikshit; Shailendra Asthana
Journal:  Comput Struct Biotechnol J       Date:  2022-07-11       Impact factor: 6.155

4.  A Bionic-Homodimerization Strategy for Optimizing Modulators of Protein-Protein Interactions: From Statistical Mechanics Theory to Potential Clinical Translation.

Authors:  Jin Yan; Xiaoqiang Zheng; Weiming You; Wangxiao He; Guang-Kui Xu
Journal:  Adv Sci (Weinh)       Date:  2022-02-15       Impact factor: 16.806

5.  Aromatic clusters in protein-protein and protein-drug complexes.

Authors:  Esteban Lanzarotti; Lucas A Defelipe; Marcelo A Marti; Adrián G Turjanski
Journal:  J Cheminform       Date:  2020-05-08       Impact factor: 5.514

Review 6.  Application of Post Solid-Phase Oxime Ligation to Fine-Tune Peptide-Protein Interactions.

Authors:  Xue Zhi Zhao; Fa Liu; Terrence R Burke
Journal:  Molecules       Date:  2020-06-18       Impact factor: 4.411

7.  Development of R7BP inhibitors through cross-linking coupled mass spectrometry and integrated modeling.

Authors:  Poorni R Adikaram; Jian-Hua Zhang; Claire M Kittock; Mritunjay Pandey; Sergio A Hassan; Nicole G Lue; Guanghui Wang; Marjan Gucek; William F Simonds
Journal:  Commun Biol       Date:  2019-09-13

8.  Docking-based identification of small-molecule binding sites at protein-protein interfaces.

Authors:  Mireia Rosell; Juan Fernández-Recio
Journal:  Comput Struct Biotechnol J       Date:  2020-11-21       Impact factor: 7.271

9.  Mapping of the FGF14:Nav1.6 complex interface reveals FLPK as a functionally active peptide modulating excitability.

Authors:  Aditya K Singh; Paul A Wadsworth; Cynthia M Tapia; Giuseppe Aceto; Syed R Ali; Haiying Chen; Marcello D'Ascenzo; Jia Zhou; Fernanda Laezza
Journal:  Physiol Rep       Date:  2020-07

Review 10.  Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials.

Authors:  Haiying Lu; Qiaodan Zhou; Jun He; Zhongliang Jiang; Cheng Peng; Rongsheng Tong; Jianyou Shi
Journal:  Signal Transduct Target Ther       Date:  2020-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.